About
reNEW aims to pave the way for future stem cell-based treatments.
The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, aims to pave the way for future stem cell-based treatments as well as stimulate a new wave of global investment in stem cell medicine and technologies, and create highly skilled jobs in this advancing medical field.
The establishment of reNEW has been made possible by the €300M investment from the Novo Nordisk Foundation in an international consortium of stem cell research. The Murdoch Children’s Research Institute on the Melbourne Children’s Campus in Parkville is one of the three institutes that form reNEW, along with the University of Copenhagen and Leiden University Medical Centre.
Vision
To advance a new generation of effective and safe stem cell-based therapies built on an international collaborative network of excellence in targeted biomedical research.
Mission
To develop an international targeted research Center to deliver innovative stem cell driven therapies to transform the lives of people with incurable disease.
Stem cell research excellence in Melbourne
The MCRI stem cell research program was established to drive the discoveries of fundamental stem cell biology toward medical outcomes for patients. It is focused on the delivery of human stem cell-based treatments, including patient disease modelling, drug screening, cell therapies and bioengineered tissues. Our stem cell research has been accelerated by world-leading research facilities that are housed at MCRI.
Our co-location within the Royal Children’s Hospital and our partnership with the University of Melbourne and other research centres ideally places MCRI to lead research, collaborate closely with clinicians, biomedical scientists, engineers, ethicists and the biotechnology sector, to deliver stem cell medical breakthroughs into the clinic.
Long term investments leading to future therapies
The Victorian and Federal governments have long supported stem cell research. Their investments have built stem cell research capabilities and paved the way towards Melbourne’s role in this international consortium of stem cell research.
We acknowledge key supporters and funders, researchers and advocacy groups as they continue to play a vital role in the work towards advancing a new generation of effective and safe stem cell-based therapies.
Proudly in partnership with
The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is supported by a Novo Nordisk Foundation grant number NNF21CC0073729